美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CapsoVision, Inc.

5.23

+0.28005.66%

盤後：5.230.00000.00%16:29 EST

成交量：22.56萬

成交額：116.20萬

市值：2.45億

市盈率：-10.85

高：5.25

開：4.97

低：4.97

收：4.95

52周最高：15.37

52周最低：3.43

股本：4,677.41萬

流通股本：525.00萬

量比：0.83

換手率：4.30%

股息：- -

股息率：- -

每股收益(TTM):-0.4820

每股收益(LYR):-9.7614

淨資產收益率：--

總資產收益率：--

市淨率：11.97

市盈率(LYR):-0.54

資料載入中...

總覽公司新聞資訊公告

2026，關於賺錢、AI與競爭邏輯的展望和預判

38歲姚班天才，又有了新身份

凤凰网科技

姚順雨、楊植麟、林俊暘、唐傑罕見同台，決定中國大模型未來的天才都來了

凤凰网科技

無錫智能自控工程股份有限公司一種閥芯雙導向的大Cv調節閥專利獲授權（工程元件專利快訊）

Capsovision, Inc.盤中異動早盤快速跳水5.18%報8.05美元

Capsovision, Inc.盤中異動股價大漲5.27%

閆俊傑應戰AI「淘汰賽」

萬諾維®在華獲批用於治療成人遺傳性轉甲狀腺素蛋白澱粉樣變性多發性神經病（ATTRv-PN）患者

美國向加勒比增派特戰飛機和部隊

浦東AI新政釋放發展活力八斗學院以人才培養銜接產業需求

當字節的AI洪水，試圖漫過微信們的堤壩

兩個「賣鏟」的程序員，不營銷卻在不到2年撬動7個億

Capsovision, Inc.盤中異動早盤股價大跌5.42%報5.15美元

Capsovision, Inc.盤中異動早盤股價大漲5.26%報5.20美元

北京民海生物科技有限公司抗柯薩奇病毒A16型的抗體及其製備方法和應用專利獲授權（生物醫藥專利快訊）

USAT網站披露重要提示：USAT不受美國聯邦存款保險公司等機構的保險保護

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CV/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CV\",,,,,undefined,":{"symbol":"CV","market":"US","secType":"STK","nameCN":"CapsoVision, Inc.","latestPrice":5.23,"timestamp":1772053200000,"preClose":4.95,"halted":0,"volume":225574,"hourTrading":{"tag":"盘后","latestPrice":5.23,"preClose":5.23,"latestTime":"16:29 EST","volume":1102,"amount":5762.5925,"timestamp":1772054978585,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05656565656565661,"floatShares":5250000,"shares":46774067,"eps":-0.482,"marketStatus":"未開盤","change":0.28,"latestTime":"02-25 16:00:00 EST","open":4.97,"high":5.25,"low":4.97,"amount":1162012.8983,"amplitude":0.056566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.482,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1772096400000},"marketStatusCode":0,"adr":0,"listingDate":1751428800000,"exchange":"NASDAQ","adjPreClose":4.95,"preHourTrading":{"tag":"盘前","latestPrice":4.99,"preClose":4.95,"latestTime":"09:29 EST","volume":15,"amount":77.95999950000001,"timestamp":1772029799076,"change":0.04,"changeRate":0.008081,"amplitude":0.082828},"postHourTrading":{"tag":"盘后","latestPrice":5.23,"preClose":5.23,"latestTime":"16:29 EST","volume":1102,"amount":5762.5925,"timestamp":1772054978585,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.825975},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CV\",,,,,undefined,":{"symbol":"CV","floatShares":5250000,"roa":"--","roe":"--","lyrEps":-9.761381,"volumeRatio":0.825975,"shares":46774067,"dividePrice":0,"high":5.25,"amplitude":0.056566,"preClose":4.95,"low":4.97,"week52Low":3.4341,"pbRate":"11.97","psRate":"18.69","week52High":15.37,"institutionHeld":0,"latestPrice":5.23,"eps":-0.482,"divideRate":0,"volume":225574,"delay":0,"ttmEps":-0.482,"open":4.97,"prevYearClose":10.69,"prevWeekClose":4.68,"prevMonthClose":5.02,"prevQuarterClose":10.69,"fiveDayClose":4.73,"twentyDayClose":5.29,"sixtyDayClose":5.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CV\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1762664400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CV","date":"2026-02-24","current":-10.850622,"percent":0.329268,"low":-29.941459,"twenty":-12.483934,"median":-10.736083,"eighty":-9.408168,"high":-8.14935,"avg":-12.148674,"sd":4.85064,"marketCap":252016550},"quantilePoints":[{"date":"2025-07-03","current":-9.676551,"twenty":-11.483601,"median":-11.210182,"eighty":-10.432678,"marketCap":203913952},{"date":"2025-07-11","current":-9.896472,"twenty":-11.155498,"median":-10.138386,"eighty":-9.676551,"marketCap":208548360},{"date":"2025-07-18","current":-10.336315,"twenty":-10.827205,"median":-10.116394,"eighty":-9.676551,"marketCap":217817176},{"date":"2025-07-25","current":-9.41699,"twenty":-10.582628,"median":-10.006433,"eighty":-9.65016,"marketCap":198444227},{"date":"2025-08-01","current":-8.523809,"twenty":-10.389096,"median":-9.841492,"eighty":-9.399347,"marketCap":179622234},{"date":"2025-08-08","current":-9.461098,"twenty":-10.217558,"median":-9.676551,"eighty":-9.180945,"marketCap":199373708},{"date":"2025-08-15","current":-8.865644,"twenty":-10.111996,"median":-9.601997,"eighty":-9.01561,"marketCap":186825713},{"date":"2025-08-22","current":-9.110791,"twenty":-10.068011,"median":-9.41699,"eighty":-8.967091,"marketCap":186160786},{"date":"2025-08-29","current":-8.996334,"twenty":-10.027633,"median":-9.260718,"eighty":-8.988166,"marketCap":183822083},{"date":"2025-09-05","current":-8.652962,"twenty":-10.01004,"median":-9.145128,"eighty":-8.881294,"marketCap":176805973},{"date":"2025-09-12","current":-8.469831,"twenty":-9.962449,"median":-9.110791,"eighty":-8.635016,"marketCap":173064047},{"date":"2025-09-19","current":-10.621625,"twenty":-10.035228,"median":-9.145128,"eighty":-8.658641,"marketCap":217031670},{"date":"2025-09-26","current":-10.415602,"twenty":-10.303934,"median":-9.306721,"eighty":-8.72891,"marketCap":212822004},{"date":"2025-10-03","current":-10.987888,"twenty":-10.443072,"median":-9.424131,"eighty":-8.839179,"marketCap":224515521},{"date":"2025-10-10","current":-10.633071,"twenty":-10.511747,"median":-9.593421,"eighty":-8.881294,"marketCap":217265541},{"date":"2025-10-17","current":-10.552951,"twenty":-10.612469,"median":-9.676551,"eighty":-8.924404,"marketCap":215628448},{"date":"2025-10-24","current":-11.239694,"twenty":-10.746933,"median":-9.786511,"eighty":-8.962681,"marketCap":229660668},{"date":"2025-10-31","current":-10.758974,"twenty":-10.758974,"median":-9.959212,"eighty":-8.984081,"marketCap":219838114},{"date":"2025-11-07","current":-10.987888,"twenty":-10.82307,"median":-10.050417,"eighty":-8.996334,"marketCap":224515521},{"date":"2025-11-14","current":-12.998634,"twenty":-10.939968,"median":-10.173983,"eighty":-9.00549,"marketCap":265601085},{"date":"2025-11-21","current":-11.067127,"twenty":-10.982209,"median":-10.336315,"eighty":-9.028365,"marketCap":249674389},{"date":"2025-11-28","current":-11.606987,"twenty":-10.987888,"median":-10.36982,"eighty":-9.046486,"marketCap":261853627},{"date":"2025-12-05","current":-13.288858,"twenty":-11.067127,"median":-10.464827,"eighty":-9.064128,"marketCap":299796640},{"date":"2025-12-12","current":-29.941459,"twenty":-11.120659,"median":-10.484277,"eighty":-9.064304,"marketCap":675479304},{"date":"2025-12-19","current":-21.905852,"twenty":-11.294633,"median":-10.541505,"eighty":-9.071575,"marketCap":494196023},{"date":"2025-12-26","current":-28.820211,"twenty":-11.420112,"median":-10.61018,"eighty":-9.097843,"marketCap":650183963},{"date":"2026-01-02","current":-22.196546,"twenty":-11.504125,"median":-10.632079,"eighty":-9.108201,"marketCap":500754075},{"date":"2026-01-09","current":-14.534689,"twenty":-12.50788,"median":-10.701745,"eighty":-9.12639,"marketCap":327902575},{"date":"2026-01-16","current":-12.562124,"twenty":-12.582888,"median":-10.745125,"eighty":-9.133004,"marketCap":283401511},{"date":"2026-01-23","current":-12.977401,"twenty":-12.819596,"median":-10.758974,"eighty":-9.147417,"marketCap":292770156},{"date":"2026-01-30","current":-11.254002,"twenty":-12.733628,"median":-10.781865,"eighty":-9.191459,"marketCap":253890279},{"date":"2026-02-06","current":-10.11199,"twenty":-12.672307,"median":-10.770419,"eighty":-9.269919,"marketCap":228126505},{"date":"2026-02-13","current":-9.779769,"twenty":-12.603652,"median":-10.754167,"eighty":-9.346418,"marketCap":220631589},{"date":"2026-02-20","current":-9.634422,"twenty":-12.523029,"median":-10.736083,"eighty":-9.390525,"marketCap":217352564},{"date":"2026-02-24","current":-11.170946,"twenty":-12.483934,"median":-10.736083,"eighty":-9.408168,"marketCap":252016550}],"updateTime":1772087948065},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CV\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607330860","title":"2026，關於賺錢、AI與競爭邏輯的展望和預判","url":"https://stock-news.laohu8.com/highlight/detail?id=2607330860","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607330860?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 18:04","pubTimestamp":1769681040,"startTime":"0","endTime":"0","summary":"峰瑞资本创始合伙人李丰，在混沌学园的年度重磅分享中，给出了他关于2026年的关键展望，这不仅是一次关于AI技术的讨论，更是一场关于钱、科技创新与AI产业竞争逻辑的深度复盘。然后2020年，疫情爆发。而2022年，中国仍处于疫情防控中。从2022年三季度开始，全球资金涌入美元资产，资产价格自然上涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656148585&idx=3&sn=aef6231b0f7f2c54eae1c5610effe6d3&chksm=67f09a68b6247d5e90949820a245142e97d4bafa74ba5566d6b70dd1b424b616242dbf984015&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4532","BK4020","BK4082","BK4023","BK4551","BK4585","CV","BK4588","BK4543","BK4587","BK4528","UI"],"gpt_icon":1},{"id":"2606607262","title":"38歲姚班天才，又有了新身份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606607262","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606607262?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 09:12","pubTimestamp":1769389942,"startTime":"0","endTime":"0","summary":"1月26日，凤凰网科技获悉，千里科技董事长印奇正式出任AI创业公司阶跃星辰董事长。38岁姚班天才，再履新2011年，印奇与清华姚班的同学共同创立旷视科技。阶跃星辰自2023年创立以来，一直被视为中国AGI赛道的重要玩家。近期，阶跃星辰也发布了一系列模型进展。从痴迷机器人的少年，到姚班天才，再到AI四小龙创始人，如今同时执掌两家硬核科技公司，印奇正在向其目标逼近。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8qDtUkLjVsL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4528","CV","BK4023","AI","BK4082","BK4587","BK4588","BK4543","BK4551","BK4585"],"gpt_icon":0},{"id":"2602314525","title":"姚順雨、楊植麟、林俊暘、唐傑罕見同台，決定中國大模型未來的天才都來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2602314525","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602314525?lang=zh_tw&edition=fundamental","pubTime":"2026-01-10 22:18","pubTimestamp":1768054717,"startTime":"0","endTime":"0","summary":"在他们身后，是中国开源大模型力量在全球舞台上的集体崛起。姚顺雨展现乐观，认为中国在技术复现和工程优化上优势明显。2025年也成为了姚顺雨的转折年，凤凰网科技在当年9月获悉，姚顺雨规划回国，并接触了多家大厂。这个转折直到2025年12月才揭晓，姚顺雨正式加入腾讯并出任首席AI科学家，同时兼任新成立的AI Infra部及大语言模型部负责人，全面负责腾讯大模型研发体系。姚顺雨加入腾讯后的首次公开露面贡献给了这个重要的场合。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8pnW6m8vH2j","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4202","RL","BK4082","LU0006061336.USD","BK4587","BK4528","BK4543","CV","BK4551","BK4585","BK4588","LU0054578231.USD","BK4023","AI"],"gpt_icon":1},{"id":"2601872675","title":"無錫智能自控工程股份有限公司一種閥芯雙導向的大Cv調節閥專利獲授權（工程元件專利快訊）","url":"https://stock-news.laohu8.com/highlight/detail?id=2601872675","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601872675?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 16:06","pubTimestamp":1767773163,"startTime":"0","endTime":"0","summary":"天眼查App显示，2026-01-06，“一种阀芯双导向的大Cv调节阀”正式进入专利权的授权阶段。申请人为无锡智能自控工程股份有限公司，该项工程元件或部件；为产生和保持机器或设备的有效运行的一般措施；一般绝热;专利涉及工业流体控制阀门技术领域，尤其适用于高流量系数与高稳定导向需求的调节阀场景。据专利信息显示，该调节阀通过阀芯双导向结构设计及等角度分布流通腔布局，在保证大Cv值的同时实现显著优化的导向性能和运行稳定性。发明人为华剑;韩良云;徐晓禹;周政宇。本实用新型采用圆柱式阀芯结构，阀芯中部及下部设有多处均布连通的流通腔，配合阀座中孔与阀芯导向面的精密适配，提升了流量调节精度与结构可靠性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107160708a4a6c3fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107160708a4a6c3fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CV","BK4082"],"gpt_icon":0},{"id":"2601872621","title":"Capsovision, Inc.盤中異動 早盤快速跳水5.18%報8.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601872621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601872621?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 23:23","pubTimestamp":1767713026,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日23时23分，Capsovision, Inc.股票出现波动，股价大幅跳水5.18%。Capsovision, Inc.股票所在的医疗器械行业中，整体涨幅为2.23%。其相关个股中，Neuroone Medical Technologies Corporation、Intelligent Bio Solutions Inc.、Neuronetics, Inc.涨幅较大，Intelligent Bio Solutions Inc.、沃氪医疗、Profusa, Inc.较为活跃，换手率分别为69.20%、10.35%、7.77%，振幅较大的相关个股有Intelligent Bio Solutions Inc.、Pavmed Inc.、Profusa, Inc.，振幅分别为24.36%、15.19%、14.74%。Capsovision, Inc.公司简介：CapsoVision Inc是一家商业阶段的医疗技术企业，创新、制造和市场化以内镜视频成像设备为主，专注于胃肠道系统的内部成像。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106232346a6faf45a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106232346a6faf45a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CV"],"gpt_icon":0},{"id":"2595835774","title":"Capsovision, Inc.盤中異動 股價大漲5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595835774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595835774?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 22:39","pubTimestamp":1767105581,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日22时39分，Capsovision, Inc.股票出现波动，股价快速上涨5.27%。Capsovision, Inc.股票所在的医疗器械行业中，整体涨幅为0.01%。其相关个股中，Profusa, Inc.、Autonomix Medical, Inc.、Capsovision, Inc.涨幅较大，沃氪医疗、Autonomix Medical, Inc.、Profusa, Inc.较为活跃，换手率分别为2856.46%、1107.96%、374.60%，振幅较大的相关个股有Profusa, Inc.、Autonomix Medical, Inc.、沃氪医疗，振幅分别为42.90%、27.83%、11.73%。Capsovision, Inc.公司简介：CapsoVision Inc是一家商业阶段的医疗技术企业，创新、制造和市场化以内镜视频成像设备为主，专注于胃肠道系统的内部成像。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230223941953bd4a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230223941953bd4a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CV"],"gpt_icon":0},{"id":"2595207204","title":"閆俊傑應戰AI「淘汰賽」","url":"https://stock-news.laohu8.com/highlight/detail?id=2595207204","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595207204?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 15:30","pubTimestamp":1766993410,"startTime":"0","endTime":"0","summary":"即将迈入2026年，AI行业共识再次发生质变，单纯的模型参数竞赛已遭遇边际效应递减。闫俊杰敏锐地感知到，AI1.0时代的“识别”已触及天花板，而基于Transformer架构的“生成”与“交互”才是通往 AGI 的钥匙。2021年冬，闫俊杰做了一个违背当时创投圈共识的决定，切入ToC赛道。尽管官方未披露具体原因，且彼时生成式AI的备案细则尚未落地，但“水面之下”的暗礁已现。这解释了为什么闫俊杰在内部将“效率”视为最高纲领。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1766747104635093060","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["CV","BK4588","BK4543","BK4082","BK4585","BK4528","AI","BK4551","BK4587","BK4023"],"gpt_icon":0},{"id":"2594236078","title":"萬諾維®在華獲批用於治療成人遺傳性轉甲狀腺素蛋白澱粉樣變性多發性神經病（ATTRv-PN）患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2594236078","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594236078?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 17:10","pubTimestamp":1766653800,"startTime":"0","endTime":"0","summary":"依普隆特生钠是中国首个且目前唯一获批用于ATTRv-PN治疗的基因沉默剂。\" 依普隆特生钠已在美国和欧盟获批用于治疗ATTRv-PN，并正在全球更多国家和地区推进审批进程。依普隆特生钠目前正在开展CARDIO-TTRansform III期临床研究，旨在评估其用于治疗成人转甲状腺素蛋白心脏淀粉样变心肌病的疗效。作为RNA靶向治疗药物，它可在肝脏源头减少TTR蛋白的产生，因而具有潜力用于治疗各类型的转甲状腺素蛋白介导的淀粉样变性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4853711_ZH53711_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4082","BK4007","LU0320765992.SGD","ATTR","HF","LU0109394709.USD","LU2456880835.USD","LU2462157665.USD","LU1829250122.USD","BK4585","BK4588","LU2417539215.USD","LU0889565916.HKD","CV","AZN","BK4568","LU2236285917.USD"],"gpt_icon":0},{"id":"2593344663","title":"美國向加勒比增派特戰飛機和部隊","url":"https://stock-news.laohu8.com/highlight/detail?id=2593344663","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593344663?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 02:52","pubTimestamp":1766515920,"startTime":"0","endTime":"0","summary":"△CV-22型“鱼鹰”倾转旋翼机（资料图）\n央视记者当地时间23日获悉，美国已向加勒比地区增派多架特种作战飞机和部队，包括至少10架CV-22型“鱼鹰”倾转旋翼机，以进一步向委内瑞拉政府施压。（央视记者 朱磊）\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：丁文武","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-24/doc-inhcvvxw0174174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4082","SINA","CV"],"gpt_icon":0},{"id":"2591660586","title":"浦東AI新政釋放發展活力 八斗學院以人才培養銜接產業需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660586","media":"鲁南网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591660586?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 14:02","pubTimestamp":1765864920,"startTime":"0","endTime":"0","summary":"浦东AI新政的出台为区域产业发展注入了强心剂，而人才供给则是确保政策目标落地的关键变量。这种将区域政策导向转化为具体人才培养实践的探索，不仅为浦东AI产业发展提供了人才支撑，也为AI教育机构衔接区域产业需求提供了可参考的路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-16/doc-inhaymzp8559973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4551","BK6511","BK4543","BK4588","5RE.SI","CV","AI","BK4023","BK4082","BK4587","BK4585","BK4528","BK6092"],"gpt_icon":0},{"id":"2590406465","title":"當字節的AI洪水，試圖漫過微信們的堤壩","url":"https://stock-news.laohu8.com/highlight/detail?id=2590406465","media":"锦缎","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590406465?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 07:59","pubTimestamp":1765497590,"startTime":"0","endTime":"0","summary":"作为对排山倒海而来的阻力的应对，豆包已于12月5日宣布对AI操作能力进行规范化调整，暂时下线金融、支付类应用的操作能力，并限制刷分、刷激励及部分游戏场景。事实上，智谱此举并非首次尝试。如今的AI手机助手，正面临相似的关口。短期内，视觉识别与多模态模型的持续进化，仍将为AI助手提供绕过API封锁的技术路径。主流手机厂商也早已将自研AI助手定为核心战略，系统层的AI主导权之争，实则早已悄然展开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8p16HANwBIN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4023","BK4587","BK4585","AI","BK4528","BK4588","BK4082","BK4551","BK4543","CV"],"gpt_icon":0},{"id":"2588713690","title":"兩個「賣鏟」的程序員，不營銷卻在不到2年撬動7個億","url":"https://stock-news.laohu8.com/highlight/detail?id=2588713690","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588713690?lang=zh_tw&edition=fundamental","pubTime":"2025-11-30 11:05","pubTimestamp":1764471900,"startTime":"0","endTime":"0","summary":"也就是说，更像是个“卖铲人”。从1990年以来，有超过97个人入选该榜单。这种“反向推销”的现象，充分反映了Reducto在硅谷的影响力。Reducto的“Agentic OCR”用一个“AI质检员”取代了“人类审核员”。这是一个“AI监督AI”的自修正系统。Reducto在核心产品发布后的6个月内，ARR从0增长到“7位数”，超过100万美元。到2025年4月A轮融资时，Reducto已经处理了“数亿页”文档；而在2025年10月的B轮融资时，累计处理量超过了“10亿页”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656134601&idx=1&sn=3ae9603136575912c90480d6a456f1dd&chksm=67f48a616764c309a6a38129d293133662ced83cffe2db867b64479ef12d988dd191ab0aecb0&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["API","LU0316494557.USD","BK4514","IE00BKVL7J92.USD","CV","LU0348723411.USD","LU0417517546.SGD","LU0127658192.USD","BK4534","LU2360106780.USD","LU2404859667.USD","LU1934455863.HKD","MIT","LU0310800379.SGD","LU0096362180.USD","IE00B19Z8W00.USD","LU0211331839.USD","LU1074936037.SGD","CTO","LU0342679015.USD","LU0251132253.USD","LU0742534661.SGD","LU1880398471.USD","LU1261432733.SGD","LU1935043536.SGD","LU0154236417.USD","LU1244550221.USD","IE00BJJMRY28.SGD","USJW.SI","BK4585","LU1221951129.SGD","LU2054465674.USD","LU2746668461.USD","AI","SG9999018865.SGD","LU1323610961.USD","LU1066051811.HKD","LU2456880835.USD","PMF","LU0861579265.USD","CEO","LU2237443978.SGD","IE00BZ199S13.USD","LU0079474960.USD","LU0980610538.SGD","LU0868494617.USD","LU0985320562.USD","LU2023250330.USD"],"gpt_icon":1},{"id":"2583253273","title":"Capsovision, Inc.盤中異動 早盤股價大跌5.42%報5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583253273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583253273?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 23:33","pubTimestamp":1762961596,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日23时33分，Capsovision, Inc.股票出现波动，股价快速下挫5.42%。截至发稿，该股报5.15美元/股，成交量1.3401万股，换手率0.03%，振幅4.96%。Capsovision, Inc.股票所在的医疗器械行业中，整体涨幅为0.66%。Capsovision, Inc.公司简介：CapsoVision Inc是一家商业阶段的医疗技术企业，创新、制造和市场化以内镜视频成像设备为主，专注于胃肠道系统的内部成像。公司的产品包括已经上市的CapsoCam Plus，针对小肠，以及正在开发中的CapsoColon 3D，针对大肠。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223331695003004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223331695003004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CV"],"gpt_icon":0},{"id":"2582999623","title":"Capsovision, Inc.盤中異動 早盤股價大漲5.26%報5.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582999623","media":"市场透视","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582999623?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 22:43","pubTimestamp":1762872188,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日22时43分，Capsovision, Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报5.20美元/股，成交量7936股，换手率0.02%，振幅4.45%。Capsovision, Inc.股票所在的医疗器械行业中，整体涨幅为0.46%。Capsovision, Inc.公司简介：CapsoVision Inc是一家商业阶段的医疗技术企业，创新、制造和市场化以内镜视频成像设备为主，专注于胃肠道系统的内部成像。公司的产品包括已经上市的CapsoCam Plus，针对小肠，以及正在开发中的CapsoColon 3D，针对大肠。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111122430894fdde1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111122430894fdde1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CV"],"gpt_icon":0},{"id":"2576927040","title":"北京民海生物科技有限公司抗柯薩奇病毒A16型的抗體及其製備方法和應用專利獲授權（生物醫藥專利快訊）","url":"https://stock-news.laohu8.com/highlight/detail?id=2576927040","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576927040?lang=zh_tw&edition=fundamental","pubTime":"2025-10-18 14:14","pubTimestamp":1760768043,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025-10-17，“抗柯萨奇病毒A16型的抗体及其制备方法和应用”正式进入专利权的授权阶段。申请人为北京民海生物科技有限公司，该项生物医药专利涉及抗柯萨奇病毒A16型的抗体研发与应用。据专利信息显示，该抗体或其抗原结合片段可特异性结合并中和CV-A16毒株及其抗原，对CV-A16感染动物具有良好的保护作用，技术效果数据提升达显著优化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251018141626a6bfec47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251018141626a6bfec47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CV","BK4082"],"gpt_icon":0},{"id":"2567187553","title":"USAT網站披露重要提示：USAT不受美國聯邦存款保險公司等機構的保險保護","url":"https://stock-news.laohu8.com/highlight/detail?id=2567187553","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567187553?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 21:04","pubTimestamp":1757768650,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usat.io/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["LU1861220207.SGD","CRCL","USDT.USD.CC","BK4023","161027","LU2360107671.USD","LU1791807156.HKD","LU1668664300.SGD","USDT.USD.HKCC","BK4082","CV","LU0106831901.USD","SIPC","LU1861217088.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}